Telehealth and virtual health monitoring in cystic fibrosis.
Journal
Current opinion in pulmonary medicine
ISSN: 1531-6971
Titre abrégé: Curr Opin Pulm Med
Pays: United States
ID NLM: 9503765
Informations de publication
Date de publication:
01 11 2021
01 11 2021
Historique:
pubmed:
26
8
2021
medline:
15
10
2021
entrez:
25
8
2021
Statut:
ppublish
Résumé
At many institutions, the Covid-19 pandemic made it necessary to rapidly change the way services are provided to patients, including those with cystic fibrosis (CF). The purpose of this review is to explore the past, present and future of telehealth and virtual monitoring in CF and to highlight certain challenges/considerations in developing such services. The Covid-19 pandemic has proven that telehealth and virtual monitoring are a feasible means for safely providing services to CF patients when traditional care is not possible. However, both telehealth and virtual monitoring can also provide further support in the future in a post-covid era through a hybrid-model incorporating traditional care, remote data collection and sophisticated platforms to manage and share data with CF teams. We provide a detailed overview of telehealth and virtual monitoring including examples of how paediatric and adult CF services adapted to the need for rapid change. Such services have proven popular with people with CF meaning that co-design with stakeholders will likely improve systems further. In the future, telehealth and virtual monitoring will become more sophisticated by harnessing increasingly powerful technologies such as artificial intelligence, connected monitoring devices and wearables. In this review, we harmonise definitions and terminologies before highlighting considerations and limitations for the future of telehealth and virtual monitoring in CF.
Identifiants
pubmed: 34431789
doi: 10.1097/MCP.0000000000000821
pii: 00063198-202111000-00010
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
544-553Informations de copyright
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.
Références
Maheu M, Whitten P, Allen A. E-Health, Telehealth, and Telemedicine: a guide to startup and success. New York, USA: John Wiley & Sons; 2002.
Wittson CL, Affleck DC, Johnson V. Two-way television in group therapy. Ment Hosp 1961; 12:22–23.
Willemain TR, Mark RG. Models of remote healthcare systems. Biomed Sci Instrument 1971; 8:9–17.
McLendon K. E-commerce and HIM: ready or not, here it comes. J AHIMA 2000; 71:22–23.
Fatehi F, Wootton R. Telemedicine, telehealth or e-health? A bibliometric analysis of the trends in the use of these terms. J Telemed Telecare 2012; 18:460–464.
U.S. Food and Drug Administration. What is digital health? [Internet]. U.S. Food and Drug Administration. 2021 [cited 23 June 2021]. https://www.fda.gov/medical-devices/digital-health-center-excellence/what-digital-health
Bashshur RL, Reardon TG, Shannon GW. Telemedicine: a new healthcare delivery system. Ann Rev Public Health 2000; 21:613–637.
Sood S, Mbarika V, Jugoo S, et al. What is telemedicine? A collection of 104 peer-reviewed perspectives and theoretical underpinnings. Telemed J E Health 2007; 13:573–590.
Kerem BS, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989; 245:1073–1080.
Finkelstein SM, Budd JR, Warwick WJ, et al. Compliance measures for home monitoring in cystic fibrosis. Annual International Conference of the IEEE Engineering in Medicine and Biology-Proceedings 1984 Dec 1. Institute of Electrical and Electronics Engineers Inc.
Finkelstein SM, Budd JR, Warwick WJ, et al. Home monitoring in cystic fibrosis: a model program. InIEEE/Engineering in Medicine and Biology Society Annual Conference 1985 Dec 1 (657-659). IEEE.
Finkelstein SM, Wielinski CL, Kujawa SJ, et al. The impact of home monitoring and daily diary recording on patient status in cystic fibrosis. Pediatr Pulmonol 1992; 12:3–10.
Finkelstein SM, Budd JR, Warwick WJ, et al. Feasibility and compliance studies of a home measurement monitoring program for cystic fibrosis. J Chronic Dis 1986; 39:195–205.
Magrabi F, Lovell NH, Henry RL, Celler BG. Designing home telecare: a case study in monitoring cystic fibrosis. Telemed J E Health 2005; 11:707–719.
Piazza-Waggoner C, Ferguson KS, Daines C, et al. Case study: providing evidence-based behavioral and nutrition treatment to a toddler with cystic fibrosis and multiple food allergies via telehealth. Pediatr Pulmonol 2006; 41:1001–1004.
Wilkinson OM, Duncan-Skingle F, Pryor JA, Hodson ME. A feasibility study of home telemedicine for patients with cystic fibrosis awaiting transplantation. J Telemed Telecare 2008; 14:182–185.
Bella S, Murgia F, Tozzi AE, et al. Five years of telemedicine in cystic fibrosis disease. Clin Ter 2009; 160:457–460.
Thornton C, Lamptey O, Chan E. The use of telehealth system in improving adherence to nebulised treatment in children with cystic fibrosis: benefits and pitfalls. Eur Respir J 2014; 44: (Suppl 58): 1965.
Goss CH, West N, Allgood S, et al. Weekly adherence is high in an ongoing one year cystic fibrosis home monitoring trial in CF, The eICE study. In D13. Use of e-health in pulmonary and critical care medicine 2014 May (A5359-A5359). American Thoracic Society.
Calvo-Lerma J, Hulst JM, Asseiceira I, et al. Nutritional status, nutrient intake and use of enzyme supplements in paediatric patients with cystic fibrosis; a European multicentre study with reference to current guidelines. J Cyst Fibros 2017; 16:510–518.
Calvo-Lerma J, Martinez-Jimenez CP, Lázaro-Ramos JP, et al. Innovative approach for self-management and social welfare of children with cystic fibrosis in Europe: development, validation and implementation of an mHealth tool (MyCyFAPP). BMJ Open 2017; 7:e014931.
O’Hayer CF, Edouard G, Bennett DS, et al. ACT via Telehealth: acceptance-based behavioral therapy for anxiety and depression among individuals with cystic fibrosis. In: Pediatric pulmonology. Hoboken, NJ: Wiley; 2017. pp. S476.
Raywood E, Douglas H, Kapoor K, et al. Protocol for Project Fizzyo, an analytic longitudinal observational cohort study of physiotherapy for children and young people with cystic fibrosis, with interrupted time-series design. BMJ Open 2020; 10:e039587.
Drabble SJ, O’Cathain A, Scott AJ, et al. Mechanisms of action of a web-based intervention with health professional support to increase adherence to nebulizer treatments in adults with cystic fibrosis: qualitative interview study. J Med Internet Res 2020; 22:e16782.
Thee S, Stahl M, Fischer R, et al. A multicentre, randomized, controlled trial on coaching and telemonitoring in patients with cystic fibrosis: conneCT CF. BMC Pulm Med 2021; 21:1–11.
Moore MA, Coffman M, Jetty A, et al. Graham center policy one-pagers: only 15% of FPs report using Telehealth; training and lack of reimbursement are top barriers. Am Fam Physician 2016; 93:101.
Kane CK, Gillis K. The use of telemedicine by physicians: still the exception rather than the rule. Health Aff (Millwood) 2018; 37:1923–1930.
World Health Organization. Rational use of personal protective equipment for coronavirus disease (COVID-19): interim guidance, 27 February. Geneva, Switzerland: World Health Organization; 2020.
Koonin LM, Hoots B, Tsang CA, et al. Trends in the use of telehealth during the emergence of the COVID-19 pandemic: United States, January–March 2020. Morb Mortal Wkly Rep 2020; 69:1595.
Dasenbrook E. Keep cystic fibrosis patients out of the hospital. Clevel Clin J Med 2020.
Compton M, Soper M, Reilly B, et al. A feasibility study of urgent implementation of cystic fibrosis multidisciplinary telemedicine clinic in the face of COVID-19 pandemic: single-center experience. Telemed e-Health 2020; 26:978–984.
Healthdirect Australia. We are Healthdirect Australia [Internet]. About.healthdirect.gov.au. 2021 [cited 23 June 2021]. https://about.healthdirect.gov.au/we-are-healthdirect-australia
Logie K, Welsh L, Ranganathan SC. Telehealth spirometry for children with cystic fibrosis. Arch Dis Child 2020; 105:1203–1205.
Shanthikumar S, Moore E, Corda J, et al. Patient and family perspectives regarding the use of telehealth for cystic fibrosis care. Pediatr Pulmonol 2021; 56:811–813.
Morrissy D, Vagg T, McCarthy M, et al. P140 TeCC (TeleMedicine, Cystic Fibrosis, Corona-Virus) study in a previous telemedicine-naive centre: clinical challenges, outcomes, and user experience in the first six months of a global pandemic. J Cyst Fibros 2021; 20:S81–S82.
Thayer EK, Pam M, Al Achkar M, et al. Best practices for virtual engagement of patient-centered outcomes research teams during and after the COVID-19 pandemic: qualitative study. J Particip Med 2021; 13:e24966.
Moore JE, Millar BC, McCaughan J, et al. The virtual CF clinic: implications for sputum microbiology. J Cyst Fibros 2020; https://doi.org/10.1016/j.jcf.2020.10.005
doi: 10.1016/j.jcf.2020.10.005
Davies G, Rowbotham NJ, Smith S, et al. Characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trials. J Cyst Fibros 2020; 19:499–502.
Lechtzin N, Mayer-Hamblett N, West NE, et al. Home monitoring of patients with cystic fibrosis to identify and treat acute pulmonary exacerbations. eICE study results. Am J Respir Crit Care Med 2017; 196:1144–1151.
Royal Papworth Hospital NHS Foundation Trust. Project Breathe | Home monitoring for cystic fibrosis patients [Internet]. Royal Papworth Hospital. 2021 [cited 23 June 2021]. https://royalpapworth.nhs.uk/our-hospital/latest-news/cloud-based-health-monitoring-cystic-fibrosis-covid-19
Quer G, Radin JM, Gadaleta M, et al. Wearable sensor data and self-reported symptoms for COVID-19 detection. Nat Med 2021; 27:73–77.
Dorsey ER, Topol EJ. Telemedicine 2020 and the next decade. Lancet 2020; 395:859.
HSE. HSE Cyber Security Incident [Internet]. HSE.ie. 2021 [cited 23 June 2021]. https://www.hse.ie/eng/services/news/media/pressrel/hse-cyber-security-incident.html
Warren M. The digital vicious cycle: links between social disadvantage and digital exclusion in rural areas. Telecommun Policy 2007; 31 (6–7):374–388.
Kruse C, Fohn J, Wilson N, et al. Utilization barriers and medical outcomes Commensurate with the use of telehealth among older adults: systematic review. JMIR Med Inform 2020; 8:e20359.
Foster MV, Sethares KA. Facilitators and barriers to the adoption of telehealth in older adults: an integrative review. Comput Inform Nurs 2014; 32:523–533.
Wootton R, Bonnardot L. Telemedicine in low-resource settings. Front Public Health 2015; 3:3.
Benz C, Middleton A, Elliott A, Harvey A. Physiotherapy via telehealth for acute respiratory exacerbations in paediatric cystic fibrosis. J Telemed Telecare 2021; https://doi.org/10.1177/1357633X21998205https://doi.org/10.1177/1357633X21998205 . [Online ahead of print].
doi: 10.1177/1357633X21998205
van Koningsbruggen-Rietschel S, Dunlevy F, Bulteel V, et al. Protecting clinical trials in cystic fibrosis; COVID-19 Mitigation Measures Crowd Sourced from the European Cystic Fibrosis Society Clinical Trials Network. doi: 10.21203/rs.3.rs-297415/v1.
Ray TR, Ivanovic M, Curtis PM, et al. Soft, skin-interfaced sweat stickers for cystic fibrosis diagnosis and management. Sci Transl Med 2021; 13:47–56.